Ingrid J Hickman, Nuala M Byrne, Ilaria Croci, Veronique S Chachay, Andrew D Clouston, Andrew P Hills, Elisabetta Bugianesi, Jonathan P Whitehead, AmaliaGastaldelli, Trisha M O?Moore-Sullivan, Johannes B Prins and Graeme A Macdonald
Aims: Type 2 diabetes is a risk factor for the development and progression of non-alcoholic fatty liver disease (NAFLD). Lifestyle intervention is the principal..Veja mais»
Hamat I, Youssouf M, Kane Y, Mahamat AA, Guillaume MA, Lemrabott TA , Said HY, Tondi ZMM, Akomola SK, Abdelkerim CS, Manna AA, Abdelaziz NH, Hapsita MA, Mahamat AH, Fary KAE, Niang A, Boucar D and Lucien A
Introduction: The Bourneville’s disease also called the tuberous sclerosis is a rare genetic disorder with a prevalence of about 1 case per 6000 living bi..Veja mais»
Sung Woo Jang,Dae Ro Lim,Jung Chul Kuk,Tae Hyung Kim,Eung Jin Shin*
Purpose: The aim of the present study was to analyze the peri- and post-operative and oncologic outcomes for ascending colon cancer after complete mesocolic excision (CME) with ..Veja mais»
Elena Matteucci, Luca Della Bartola and Ottavio Giampietro
Background: There is controversy about absolute number, frequency, and status of homing markers of regulatory T (Treg) cells in patients with type 1 diabetes. We observed recent..Veja mais»
Strom Joy
The kidney on the opposing side may grow to make up for the lost renal mass following a Radical Nephrectomy (RN) for a renal malignancy. The capacity for compensating will deter..Veja mais»
Ergun Oksuz, Simten Malhan, Begum Urganci and Erkan Tetik
Objective: The aim of the present study is to evaluate linagliptin and sitagliptin in terms of pharmacoeconomics, by comparing the two dipeptidyl-peptidase 4 inhibitors (DPP-4i)..Veja mais»